about
Integrins as Therapeutic Targets for Respiratory DiseasesIntegrin targeted delivery of chemotherapeuticsIntegrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumorsIntegrin inhibitors as a therapeutic agent for ovarian canceraV integrins and TGF-β-induced EMT: a circle of regulationDual-functional c(RGDyK)-decorated Pluronic micelles designed for antiangiogenesis and the treatment of drug-resistant tumor.A cyclic HSV1-TK reporter for real-time PET imaging of apoptosis.Combined chemotherapy delivered by nanoparticulate systems: an old concept with modern innovations.Therapeutic face of RNAi: in vivo challenges.Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation.Design, synthesis and biological evaluation of novel dimeric and tetrameric cRGD-paclitaxel conjugates for integrin-assisted drug delivery.RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.Bone-stromal cells up-regulate tumourigenic markers in a tumour-stromal 3D model of prostate cancerA novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.Polymeric micelles for multidrug delivery and combination therapy.An Overview of Nanoparticle Based Delivery for Treatment of Inner Ear Disorders.Engineered mesenchymal stem cells with enhanced tropism and paracrine secretion of cytokines and growth factors to treat traumatic brain injury.
P2860
Q33668635-7736D1E2-134E-4BD5-A357-DBBC8F8EE83DQ34912725-78CFF3B8-479E-4B76-A150-4CA3A45BFAC3Q35556993-B19A5E60-0C23-461C-975C-7584D6C9594FQ35660004-C5E70354-9FEC-4D84-903D-01E61B23802FQ35791382-2B9942C1-5953-4F04-9B4E-90EA88C9BE52Q35918831-95076CEA-B421-4472-9487-63EB2975F54AQ37702009-5D4EAADD-76E8-405C-9FD0-342DB90A028BQ38074438-E8335CEA-98E0-4F9D-A500-3E5F220BE113Q38268541-57B92EE8-FF0B-4A50-AC6B-06D3331D1287Q38501776-953405FC-78E7-4DB4-85F5-8E54BFA0F4D7Q38864088-13765D7A-C305-487D-9984-010CD0F5DC7FQ38897848-8C29AA49-8F49-4784-A2B9-1D2C84A09337Q39090627-CBC2476A-0039-433B-9E82-1F5FB9322608Q39237707-9EDE159F-7864-40B8-BDBE-29E32D84D595Q39367399-3167B563-6EC4-46C4-BD61-99B4D297290BQ45887696-74E6DFBD-5477-4498-8691-87087FBD2462Q48474574-6E4B0B63-0013-4D06-BACE-56D88F22D862
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Integrin targeted drug and gene delivery.
@en
Integrin targeted drug and gene delivery.
@nl
type
label
Integrin targeted drug and gene delivery.
@en
Integrin targeted drug and gene delivery.
@nl
prefLabel
Integrin targeted drug and gene delivery.
@en
Integrin targeted drug and gene delivery.
@nl
P2093
P2860
P1476
Integrin targeted drug and gene delivery.
@en
P2093
Wai-Keung Chui
P2860
P304
P356
10.1517/17425240903468696
P407
P577
2010-02-01T00:00:00Z